Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders
- 1 April 1987
- journal article
- review article
- Published by Elsevier BV in Neuroscience
- Vol. 21 (1), 1-40
- https://doi.org/10.1016/0306-4522(87)90322-8
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptakeNeuroscience Letters, 1986
- NORMAL MPTP BINDING IN PARKINSONIAN SUBSTANTIA NIGRA: EVIDENCE FOR EXTRANEURONAL TOXIN CONVERSION IN HUMAN BRAINThe Lancet, 1985
- III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeysLife Sciences, 1985
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathwayExperimental Neurology, 1979
- Evidence for branched subthalamic nucleus projections to substantia nigra, entopeduncular nucleus and globus pallidusNeuroscience Letters, 1978
- Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeJournal of Neural Transmission, 1977
- Chemical stimulation of discrete brain loci as a method of producing dyskinesia models in primatesExperimental Neurology, 1972
- Topical distribution of the striatal efferents in the monkeyExperimental Neurology, 1962
- Localization of an experimental hypothalamic and midbrain syndrome simulating sleepJournal of Comparative Neurology, 1954